TickerFactsScreenerDevelopers

ADMA BIOLOGICS, INC. (ADMA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: -$1.43M2012: -$6.90M2013: -$10.89M2014: -$14.70M2015: -$15.42M2016: -$18.27M2017: -$37.27M2018: -$62.68M2019: -$76.19M2020: -$102.00M2021: -$112.37M2022: -$59.51M2023: $8.80M2024: $118.67M2025: $50.40M$50.40M
2011Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$50.40M-57.5%
2024$118.67M+1248.5%
2023$8.80M+114.8%
2022-$59.51M+47.0%
2021-$112.37M-10.2%
2020-$102.00M-33.9%
2019-$76.19M-21.6%
2018-$62.68M-68.2%
2017-$37.27M-104.0%
2016-$18.27M-18.5%
2015-$15.42M-4.9%
2014-$14.70M-35.1%
2013-$10.89M-57.7%
2012-$6.90M-382.4%
2011-$1.43M—